Sign in

You're signed outSign in or to get full access.

Mark Madden

Director at WinVest Acquisition
Board

About Mark H. Madden

Mark H. Madden (age 67) is Chief Strategy Officer and a director of WinVest Acquisition Corp. (WINV). He has served as CSO since May 2021 and as a director since September 14, 2021, bringing decades of global investment management and corporate finance experience (Pioneer, OppenheimerFunds, TCW). He holds a BS from Trinity College and an MBA from the University of Virginia Darden School of Business . WINV’s board is classified; Madden is a Class I director whose term expires at the first annual meeting (which the company has not yet held) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Pioneer Investments; OppenheimerFunds; TCW GroupSenior investment leadership roles overseeing portfolio managers, analysts, product, risk, compliancePrior roles (dates not specified)Led multi‑billion investment platforms, global oversight
Covenant Advisors LLCManaging Partner2012–presentInvestment firm leadership
BWS Partners LLCManaging Member2016–presentInvestment/finance leadership

External Roles

OrganizationRoleTenureNotes
Clozex Medical, Inc. (private)Treasurer, Corporate Secretary, director; more recently ChairSince 2018Medical device (wound closure) company board leadership

Board Governance

  • Independence: Madden is not independent; WINV has determined only Kramer, McGowan, Pentland, and Schmidt are independent directors under Nasdaq/SEC rules .
  • Committee assignments: Madden is not listed on the Audit Committee (McGowan—chair, Schmidt, Kramer) or Compensation Committee (Kramer—chair, McGowan) . WINV has no standing nominating committee; independent directors handle nominations .
  • Board structure: 7‑member, staggered (Class I: Madden, McGowan, Pentland). The company may not hold an annual meeting until after a business combination .
  • Context: WINV was delisted from Nasdaq in March 2025 and trades on OTC (WINV/rights/units/warrants), heightening governance and liquidity risk .

Fixed Compensation

ComponentStructureNotes
Director/Executive cash compensationNone prior to business combination“No executive officer or director has received any cash compensation” to date; only expense reimbursement permitted .
Office/admin fee to Sponsor$10,000/monthPaid to Sponsor for office space and admin support (not paid to individual directors) .

Performance Compensation

  • None disclosed. WINV has not granted RSUs/PSUs/options to directors; any post‑combination compensation would be set by a committee of independent directors and disclosed at the time of de‑SPAC .

Other Directorships & Interlocks

  • Current external board: Clozex Medical, Inc. (private) .
  • No disclosed public company interlocks or related‑party transactions involving Madden beyond standard SPAC structures (see related-party/SPAC incentives below).

Expertise & Qualifications

  • Capital markets and global investing leadership; built and managed multi‑billion portfolios; corporate finance and investment banking experience; strategic roles across 35+ countries .

Equity Ownership

HolderSecurityAmount% of OutstandingAs of
Mark H. MaddenCommon stock (founder shares transferred to directors)28,000<1%May 9, 2024

Notes:

  • Prior to the IPO, the Sponsor transferred an aggregate 277,576 founder shares to directors for no cash consideration; such founder shares (including Madden’s) will be worthless if no business combination is completed, creating an incentive misalignment versus public investors .

Governance Assessment

  • Strengths:

    • Deep capital markets and investment oversight experience; credible financial stewardship on a SPAC board .
    • Not on Audit or Compensation—reduces concentration of power among executives; independent directors chair both committees .
  • Concerns/RED FLAGS:

    • Independence: As CSO and director, Madden is not independent; WINV’s board relies on a subset of independents for committee work .
    • Founder-share incentive: Madden beneficially owns 28,000 founder shares; founder shares were acquired at nominal cost and become worthless if no deal is closed, potentially biasing decision‑making toward completing a transaction regardless of quality .
    • SPAC/Listing risk: WINV failed to meet Nasdaq deadlines and was delisted to OTC in March 2025, which can impair governance oversight, shareholder engagement, liquidity, and investor protections .
    • Annual meeting/tenure clarity: Classified board with no annual meeting likely before a business combination; limits routine shareholder accountability .
    • Sponsor influence/financing: Significant Sponsor ownership and extension loans; insiders collectively own ~91.7% of shares as of the 2025 proxy context, magnifying insider control and potential conflicts .

Overall, Madden brings substantive financial expertise but is an executive (non‑independent) director with founder‑share incentives in a SPAC confronting delisting and multiple deadline extensions—factors that warrant heightened scrutiny of deal quality, related‑party risks, and board independence.

Equity Ownership & Alignment Details

ItemDetail
Total beneficial ownership28,000 shares; <1% of outstanding
Ownership formFounder shares transferred by Sponsor to directors (no cash consideration)
Pledging/hedgingNot disclosed
Section 16 complianceWINV reports officers and directors complied with Section 16(a) filing requirements for FY2024

Employment & Contracts

  • Start dates: CSO since May 2021; director since Sept 14, 2021 .
  • Agreements: WINV discloses no executive employment contracts or severance/termination benefits; any future compensation post‑combination to be set by independent compensation committee .

Related‑Party/Conflict Highlights

  • Founder shares & incentives: Sponsor/director founder shares acquired at nominal cost; risk factor explicitly notes insiders could profit even if the acquired company later underperforms .
  • Sponsor support & control: Sponsor receives monthly office/admin fee; has extended multiple promissory notes to fund deadline extensions; insiders collectively hold a controlling voting position, enabling approvals without public support .

Director Compensation (Structure)

ElementPolicyStatus
Cash retainer/feesNone pre‑combination
Equity awards (RSUs/PSUs/options)None disclosed pre‑combination
Expense reimbursementPermitted

No meeting fee or committee‑chair premiums disclosed; independent directors chair audit/compensation; Madden is not on those committees .

Notes on Attendance & Engagement

  • WINV has not held an annual meeting and may not do so until after a business combination; the company did not disclose per‑director board/committee attendance metrics in the 10‑K .

Risk Indicators & Red Flags (Director‑relevant)

  • Non‑independence (executive director) .
  • Founder‑share incentive misalignment .
  • Delisting to OTC and ongoing extension/delays to complete a deal .
  • Concentrated insider control—approval of key proposals without public votes .

All citations: .